Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The extracellular matrix (ECM) is a complex, non-cellular network composed of proteins like collagen and elastin, as well as glycosaminoglycans and proteoglycans, which provide essential structural and biochemical support to tissues (Frantz et al., 2010, Journal of Cell Science). Wound exudate is the fluid that leaks from blood vessels into a wound, containing a mixture of electrolytes, nutrients, inflammatory mediators, and matrix-degrading enzymes (Cutting, 2003, British Journal of Community Nursing). While the ECM and wound exudate are critical environments for therapeutic intervention, they are considered biological structures or fluids rather than specific molecular targets like a single receptor or enzyme (Theocharis et al., 2016, Advanced Drug Delivery Reviews). In pathological states such as chronic wounds or cancer, the composition of the ECM and exudate is altered, often characterized by excessive protease activity and impaired structural integrity. Drugs targeting this environment typically aim to modulate the activity of enzymes like matrix metalloproteinases (MMPs) or provide exogenous structural components to facilitate healing. For example, collagenase is used to debride necrotic tissue by breaking down damaged collagen, while advanced dressings manage exudate levels to maintain an optimal moist environment for cell migration. Understanding the interplay between the ECM and the surrounding fluid is vital for developing regenerative therapies and managing fibrotic diseases.
Enzymatic degradation of structural proteins, modulation of the wound microenvironment moisture balance, and inhibition of proteolytic activity to promote tissue regeneration.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix and wound exudate (ECM).